Bruce F. Kimler, PhD

Professor
Radiation Oncology

Bachelor of Arts, University of Texas at Austin
Master of Arts, University of Texas at Austin, Thesis: Effect of Inert Gases on the Radiation Sensitivity of Spores of Bacillus megaterium.
Doctor of Philosophy, University of Texas at Austin, Dissertation: Modification of the Water-Dependent Radiation Sensitivity of Bacterial Spores by Inert Gases.


Curriculum vitae

Dr. Kimler completed his Bachelor of Arts, Master of Arts, and Doctorate of Philosophy degrees at the University of Texas at Austin.  Dr. Kimler completed post-doctoral education in the Division of Biological and Medical Research at Argonne National Laboratory in Argonne, Illinois, and in the Laboratory of Experimental Radiation Oncology in the Department of Radiation Therapy and Nuclear Medicine at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.  Dr. Kimler has devoted the majority of his career to the Department of Radiation Oncology (formerly Department of Radiation Therapy) at the University of Kansas Medical Center.  During his career he has also held secondary appointments in the Department of Radiation Biophysics at the University of Kansas in Lawrence, Kansas and at the International Molecular Cytology Program of the Instituto de Investigaciones Citologicas de la Caja de Ahorros de Valencia in Valencia, Spain.  Dr. Kimler is currently a professor in the Department of Radiation Oncology, and holds a secondary appointment as a Graduate Faculty Member of the Department of Pharmacology, Toxicology, and Therapeutics, both at at the University of Kansas Medical Center (KUMC). 

Dr. Kimler's areas of research interest include:

  • Development and utilization of biomarkers for prediction, prevention, and detection of breast cancer; and use in the conduct of Phase I and II clinical trials of potential chemopreventive agents.
  • Analysis of clinical data for elucidation of prognostic and predictive factors related to clinical outcomes.
  • The development of biological test systems by which the interactions of ionizing radiation and cancer therapeutic modalities can be tested.  These studies assess, at the experimental level, the potential use of new combined modality therapies for cancer treatment.  Clinical trials are then conducted to evaluate the efficacy of new cancer therapeutic approaches.
  • The effect of ionizing radiation on the development of the mammalian nervous system.
Last modified: Dec 09, 2013

Bruce F. Kimler, PhD

Contact

Bruce F. Kimler, PhD
Professor

Richard and Annette Bloch Radiation Oncology Pavilion, 3901 Rainbow Boulevard, MS 4033, Kansas City, KS 66160

P: 913-588-3612

ID=x6536